Cargando…

Neutralizing antibody responses in patients hospitalized with SARS-CoV-2 Delta or Omicron infection

Detalles Bibliográficos
Autores principales:	Linderman, Susanne L., Lai, Lilin, Bocangel Gamarra, Estefany L., Lau, Max S.Y., Edupuganti, Srilatha, Surie, Diya, Tenforde, Mark W., Chappell, James D., Mohr, Nicholas M., Gibbs, Kevin W., Steingrub, Jay S., Exline, Matthew C., Shapiro, Nathan I., Frosch, Anne E., Qadir, Nida, Davis-Gardner, Meredith E., McElrath, M. Juliana, Lauring, Adam S., Suthar, Mehul S., Patel, Manish M., Self, Wesley H., Ahmed, Rafi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9711871/ https://www.ncbi.nlm.nih.gov/pubmed/36256473 http://dx.doi.org/10.1172/JCI164303

Ejemplares similares

2083. Waning of Bivalent mRNA Vaccine Effectiveness Against COVID-19-associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years – IVY Network, 20 U.S. States, September 8, 2022-April 1, 2023
por: DeCuir, Jennifer, et al.
Publicado: (2023)

BA.5 bivalent booster vaccination enhances neutralization of XBB.1.5, XBB.1.16 and XBB.1.9 variants in patients with lung cancer
por: Valanparambil, Rajesh M., et al.
Publicado: (2023)

Response to Comment: Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines Against COVID-19 Hospitalizations
por: Lewis, Nathaniel M, et al.
Publicado: (2023)

Characterizing the cytotoxic effects and several antimicrobial phytocompounds of Argemone mexicana
por: Orozco-Nunnelly, Danielle Annette, et al.
Publicado: (2021)

Correction: Characterizing the cytotoxic effects and several antimicrobial phytocompounds of Argemone mexicana
por: Orozco-Nunnelly, Danielle Annette, et al.
Publicado: (2023)

P17-25. A model for coverage of T-cell HIV vaccines: where are we and where do we need to be?
por: Self, S, et al.
Publicado: (2009)

Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells
por: Cohen, Kristen W., et al.
Publicado: (2021)

Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells
por: Cohen, Kristen W., et al.
Publicado: (2021)

Ascertainment of vaccination status by self‐report versus source documentation: Impact on measuring COVID‐19 vaccine effectiveness
por: Stephenson, Meagan, et al.
Publicado: (2022)

Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021–April 2022
por: Lewis, Nathaniel M, et al.
Publicado: (2022)

Emergent Electroweak Gravity
por: McElrath, Bob
Publicado: (2008)

Laboratory tests for the cosmic neutrino background using beta-decaying nuclei
por: McElrath, Bob
Publicado: (2009)

On The Origin of Neutrino Mass and Mixing in the Standard Model
por: McElrath, Bob
Publicado: (2009)

Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022
por: Tenforde, Mark W., et al.
Publicado: (2022)

Pericarditis Associated With Acute Zika Virus Infection in a Returning Traveler
por: Waggoner, Jesse J., et al.
Publicado: (2017)

Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States
por: Turbyfill, Caitlin, et al.
Publicado: (2022)

Comparison of mRNA vaccine effectiveness against COVID-19-associated hospitalization by vaccination source: Immunization information systems, electronic medical records, and self-report—IVY Network, February 1–August 31, 2022
por: Surie, Diya, et al.
Publicado: (2023)

1097. A Prospective Evaluation of SARS-CoV-2 Shedding and Evolution in Immunocompromised Hosts During the Omicron Period — IVY Network, 5 U.S. States, April 11, 2022 – February 1, 2023
por: Raglow, Zoe M, et al.
Publicado: (2023)

$h \to \mu^{+}\mu^{-}$ via Gluon Fusion at the LHC
por: Han, T, et al.
Publicado: (2002)

SARS-CoV-2 shedding and evolution in immunocompromised hosts during the Omicron period: a multicenter prospective analysis
por: Raglow, Zoe, et al.
Publicado: (2023)

Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies
por: Chang, Andres, et al.
Publicado: (2023)

There is no explosion risk associated with superfluid Helium in the LHC cooling system
por: Fairbairn, Malcolm, et al.
Publicado: (2008)

Poster: CLL-515 Antibody Responses Against SARS-CoV-2 Variants after Booster Vaccination in Patients With B Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
por: Chang, Andres, et al.
Publicado: (2022)

CLL-515 Antibody Responses Against SARS-CoV-2 Variants after Booster Vaccination in Patients With B Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
por: Chang, Andres, et al.
Publicado: (2022)

Prevalence of High-Intensity Drinking from Adolescence through Young Adulthood: National Data from 2016-2017
por: Patrick, Megan E, et al.
Publicado: (2019)

Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years — IVY Network, 18 States, September 8–November 30, 2022
por: Surie, Diya, et al.
Publicado: (2022)

Characteristics of Adult Outpatients and Inpatients with COVID-19 — 11 Academic Medical Centers, United States, March–May 2020
por: Tenforde, Mark W., et al.
Publicado: (2020)

Adults Hospitalized With Coronavirus Disease 2019 (COVID-19)—United States, March–June and October–December 2020: Implications for the Potential Effects of COVID-19 Tier-1 Vaccination on Future Hospitalizations and Outcomes
por: Sami, Samira, et al.
Publicado: (2021)

1108. Severity of Illness among Adults Hospitalized with Respiratory Syncytial Virus Compared with COVID-19 and Influenza — IVY Network, 25 Hospitals, 20 U.S. States, January 31, 2022 – April 11, 2023
por: Yuengling, Katharine, et al.
Publicado: (2023)

Effect of Monoclonal Antibody Treatment on Clinical Outcomes in Ambulatory Patients With Coronavirus Disease 2019
por: Anderson, Blake, et al.
Publicado: (2021)

The Innate Immune Playbook for Restricting West Nile Virus Infection
por: Quicke, Kendra M., et al.
Publicado: (2013)

Comprehensive analysis of COVID-19 during pregnancy
por: Moore, Kathryn M., et al.
Publicado: (2021)

Associations between persistent symptoms after mild COVID‐19 and long‐term health status, quality of life, and psychological distress
por: Han, Jin H., et al.
Publicado: (2022)

Winning grants step by step: the complete workbook for planning, developing, and writing successful proposals
por: O'Neal-McElrath, Tori, et al.
Publicado: (2013)

Use of B-Cell–Depleting Therapy in Women of Childbearing Potential With Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
por: Galati, Alexandra, et al.
Publicado: (2022)

Fetal growth in environmental epidemiology: mechanisms, limitations, and a review of associations with biomarkers of non-persistent chemical exposures during pregnancy
por: Kamai, Elizabeth M., et al.
Publicado: (2019)

Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged ≥60 Years — IVY Network, 20 U.S. States, February 2022–May 2023
por: Surie, Diya, et al.
Publicado: (2023)

Little Higgs models
por: Grégoire, Thomas, et al.
Publicado: (2006)

Signatures of Extra Dimensions from Upsilon Decays with a Light Gaugephobic Higgs Boson
por: Galloway, Jamison, et al.
Publicado: (2008)

Black–White Disparities in Criminal Justice Referrals to Drug Treatment: Addressing Treatment Need or Expanding the Diagnostic Net?
por: McElrath, Karen, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_cqj4bqa4n7ch57l9fr73049roa